165 related articles for article (PubMed ID: 20518843)
1. Association of SUMO4 M55V polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
Zou YF; Feng XL; Tao JH; Zhu JM; Pan FM; Su H; Ye DQ
Int J Immunogenet; 2010 Oct; 37(5):345-54. PubMed ID: 20518843
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes.
Tang ST; Peng WJ; Wang CJ; Tang HQ; Zhang Q
Diabetes Metab Res Rev; 2012 Nov; 28(8):679-87. PubMed ID: 22936652
[TBL] [Abstract][Full Text] [Related]
3. Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis.
Song GG; Choi SJ; Ji JD; Lee YH
Hum Immunol; 2012 Oct; 73(10):1055-9. PubMed ID: 22884980
[TBL] [Abstract][Full Text] [Related]
4. Association between the SUMO4 M55V Polymorphism and Susceptibility to Type 2 Diabetes Mellitus: A Meta-analysis.
Zhang Q; Liu D; Zhao ZY; Sun Q; Ding LX; Wang YX
Biomed Environ Sci; 2017 Apr; 30(4):288-295. PubMed ID: 28494838
[TBL] [Abstract][Full Text] [Related]
5. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.
Sedimbi SK; Shastry A; Park Y; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():273-7. PubMed ID: 17130565
[TBL] [Abstract][Full Text] [Related]
6. Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children.
Sang Y; Zong W; Liu M; Yan J
J Pediatr Endocrinol Metab; 2010 Oct; 23(10):1083-6. PubMed ID: 21158221
[TBL] [Abstract][Full Text] [Related]
7. No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients.
Sedimbi SK; Kanungo A; Shastry A; Park Y; Sanjeevi CB
Int J Immunogenet; 2007 Apr; 34(2):137-42. PubMed ID: 17373940
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity in association of the SUMO4 M55V variant with susceptibility to type 1 diabetes.
Noso S; Ikegami H; Fujisawa T; Kawabata Y; Asano K; Hiromine Y; Tsurumaru M; Sugihara S; Lee I; Kawasaki E; Awata T; Ogihara T
Diabetes; 2005 Dec; 54(12):3582-6. PubMed ID: 16306380
[TBL] [Abstract][Full Text] [Related]
9. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients.
Sedimbi SK; Luo XR; Sanjeevi CB; ; ; Lernmark A; Landin-Olsson M; Arnqvist H; Björck E; Nyström L; Ohlson LO; Scherstén B; Ostman J; Aili M; Bååth LE; Carlsson E; Edenwall H; Forsander G; Granström BW; Gustavsson I; Hanås R; Hellenberg L; Hellgren H; Holmberg E; Hörnell H; Ivarsson SA; Johansson C; Jonsell G; Kockum K; Lindblad B; Lindh A; Ludvigsson J; Myrdal U; Neiderud J; Segnestam K; Sjöblad S; Skogsberg L; Strömberg L; Ståhle U; Thalme B; Tullus K; Tuvemo T; Wallensteen M; Westphal O; Dahlquist G; Aman J
Genes Immun; 2007 Sep; 8(6):518-21. PubMed ID: 17554341
[TBL] [Abstract][Full Text] [Related]
10. Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations.
Noso S; Ikegami H; Fujisawa T; Kawabata Y; Asano K; Hiromine Y; Sugihara S; Lee I; Kawasaki E; Awata T; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():41-6. PubMed ID: 17130530
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population.
Tsurumaru M; Kawasaki E; Ida H; Migita K; Moriuchi A; Fukushima K; Fukushima T; Abiru N; Yamasaki H; Noso S; Ikegami H; Awata T; Sasaki H; Eguchi K
J Clin Endocrinol Metab; 2006 Aug; 91(8):3138-43. PubMed ID: 16735488
[TBL] [Abstract][Full Text] [Related]
12. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.
Gibbons LJ; Thomson W; Zeggini E; Worthington J; Barton A; Eyre S; Donn R; Hinks A
Rheumatology (Oxford); 2005 Nov; 44(11):1390-3. PubMed ID: 16159953
[TBL] [Abstract][Full Text] [Related]
13. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes.
Lin HY; Wang CL; Hsiao PJ; Lu YC; Chen SY; Lin KD; Hsin SC; Hsieh MC; Shin SJ
Diabetes; 2007 Apr; 56(4):1177-80. PubMed ID: 17229939
[TBL] [Abstract][Full Text] [Related]
14.
Li YY; Wang H; Yang XX; Geng HY; Gong G; Kim HJ; Zhou YH; Wu JJ
Front Endocrinol (Lausanne); 2017; 8():303. PubMed ID: 29163370
[TBL] [Abstract][Full Text] [Related]
15. Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes.
Sozen S; Horozoglu C; Bireller ES; Karaali Z; Cakmakoglu B
In Vivo; 2014; 28(5):919-23. PubMed ID: 25189908
[TBL] [Abstract][Full Text] [Related]
16. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-like modifier 4 M55V polymorphism is not associated with diabetic nephropathy in Iranian type 2 diabetes patients.
Shahsavar F; Jafarzadeh M; Azargoon A; Hedayati M; Asadifar B
Indian J Hum Genet; 2013 Apr; 19(2):179-82. PubMed ID: 24019619
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of MCP-1 promoter -2518 A/G polymorphism and SLE susceptibility.
Liu T; Zhai JX; Wang HY; Wang XH; Zou LW; Fan WJ; Ye DQ
Mol Biol Rep; 2012 Aug; 39(8):8475-82. PubMed ID: 22707193
[TBL] [Abstract][Full Text] [Related]
20. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes.
Qu H; Bharaj B; Liu XQ; Curtis JA; Newhook LA; Paterson AD; Hudson TJ; Polychronakos C
Nat Genet; 2005 Feb; 37(2):111-2; author reply 112-3. PubMed ID: 15678135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
